DoD Grants $2.5M for Triple-Negative Breast Cancer Therapies
The U.S. Department of Defense has awarded a $2.5 million grant to Cornell University researchers to advance targeted therapies for triple-negative breast cancer (TNBC). This research focuses on developing novel ... Read More